Ardeparin
Jump to navigation
Jump to search
Clinical data | |
---|---|
AHFS/Drugs.com | Multum Consumer Information |
Routes of administration | Injection |
ATC code |
|
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 92% |
Identifiers | |
| |
CAS Number | |
DrugBank | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.110.590 |
Chemical and physical data | |
Formula | (C26H40N2O36S5)n |
Molar mass | 5500–6500 g/mol (average) |
(what is this?) (verify) |
Ardeparin (brand name Normiflo) is an anticoagulant. It was used for the prevention of deep vein thrombosis, but was withdrawn from the US market in 2000 for reasons unrelated to safety or efficacy.[1][2][3]
References
- ^ Frishman WH, Cheng-Lai A, Chen J (2000). "Antithrombotic therapy". Current cardiovascular drugs (3rd ed.). Philadelphia, Pa.: Current Medicine. p. 90. ISBN 978-1-4615-6767-7.
- ^ "Normiflo". Drugs.com. Archived from the original on 19 February 2017. Retrieved 23 January 2018.
- ^ "Determination That Ardeparin Sodium Injection Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness". United States Food and Drug Administration. Federal Register. Retrieved 24 June 2022.
Categories:
- Articles with short description
- Short description matches Wikidata
- Use dmy dates from March 2024
- Drugs not assigned an ATC code
- Articles with changed DrugBank identifier
- Chemicals that do not have a ChemSpider ID assigned
- Articles with changed EBI identifier
- ECHA InfoCard ID from Wikidata
- Infobox-drug molecular-weight unexpected-character
- Articles without KEGG source
- Articles without InChI source
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Heparins
- Withdrawn drugs
- All stub articles
- Blood and blood forming organ drug stubs